The Patent Finder

Terms ending in 2033

Allergan, Inc.

Every in-force patent on Allergan, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,992,668Injection Device
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 9,095,506Biodegradable ALPHA-2 Agonist Polymeric Implants and Therapeutic Uses Thereof
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 9,035,071Compounds Acting at Multiple Prostaglandin Receptors Giving a General Anti-Inflammatory Response
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 9,255,068Crystalline Salts of (4S,4AS,5AR,12AS)-4-Dimethylamino-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-Carboxylic Acid Amide and Methods of Using the Same
In force
 · High confidence
Allergan Pharmaceuticals International LimitedIn forceHigh confidence
US 8,969,589Compounds Acting at Multiple Prostaglandin Receptors Giving a General Anti-Inflammatory Response
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 8,927,544BENZOFURAN-2-Sulfonamides Derivatives as Chemokine Receptor Modulators
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 9,550,746BENZOFURAN-2-Sulfonamides Derivatives as Chemokine Receptor Modulators
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 9,567,328Compounds Acting at Multiple Prostaglandin Receptors Giving a General Anti-Inflammatory Response
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 8,889,870Kinase Inhibitors
Grace period ended Nov 18, 2026 · lapse expected
 · Low confidence
Allergan, Inc.Grace period ended Nov 18, 2026
lapse expected
Low confidence
US 9,388,176Method of Treating Conditions with Kinase Inhibitors
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
48 more term ends in 2033 · Pro
10 of 58 patents shown. Soonest term end first, then patent number.
Pro members see all 58.
Upgrade to Pro
45 of these are in force and held by Allergan, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited